Leptin replacement therapy is used to alter the brain responses to food cravings in leptin-deficient adults. It’s a treatment for hereditary obesity which is not associated with the usage of highly active antiretroviral therapy (HAART). FDA recently approved the therapy to treat obese people. Leptin plays a key role to regulate energy balance, metabolism, body weight and endocrine functions. Moreover, leptin level is very low or undetectable in patients with hypothalamic amenorrhea, lipodystrophy and CLD. Tuncay Delibasi – a renowned professor from the Department of Endocrinology, Diskapi Hospital, Turkey is now doing amazing trials on the advanced level of leptin replacement therapy for obesity. Areas of use: Leptin therapy is mainly used to treat obesity, specifically related to hereditary leptin deficiency. Leptin is now medically approved for lipodystrophy – a model for usual obesity. Typical obesity can resist leptin, but it may be valuable in ...
At present Tuncay Delibasi attached to the department of endocrinology Diskapi Hospital in Turkey .